TearLab first entered the diagnostic market in 2010 with its Osmolarity System.
The first new product under Trukera Medical’s brand will be announced at the end of September.
“Our decision to rebrand as Trukera Medical represents our history as pioneers of point-of-care testing for corneal disease, while also more clearly reflecting where we’re going next,” Trukera’s CEO Adam Szaronos said in a Sept. 7 release. “We expect to see strong continued growth ahead with point-of-care diagnostics, driven primarily by practices specializing in cornea and premium cataract/refractive surgery.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.